Your session is about to expire
← Back to Search
Stress Testing for Heart Disease (DASHH Trial)
DASHH Trial Summary
This trial will explore whether two stress pathways may be linked to an increased risk for cardiovascular disease in menopausal women.
DASHH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowDASHH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DASHH Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am taking or have recently taken medications that affect my RAAS.I have taken blood pressure medication in the last 3 months.You currently have a problem with drinking alcohol or using drugs.If you are in the perimenopausal depression group, you are currently experiencing very severe depressive symptoms based on a specific test.I have a history of bipolar or psychotic disorders, or depression if not in the perimenopausal group.You have taken antihistamines in the last two weeks.I have a heart condition, diabetes, or another serious health issue.I am a woman aged 44-55 and am in the late stage of transitioning to menopause.I have thought about suicide recently and attempted it within the last 2 years.I have taken antihistamines in the last two weeks.I have used steroids in the past 3 months.I have used hormonal treatments like HRT or birth control pills in the last 30 days.I have a heart condition, diabetes, or another serious health issue.My antidepressant dose has been stable for the last 30 days.I have used steroids in the past 3 months.You currently smoke cigarettes or use nicotine products.You currently smoke cigarettes or use nicotine products.I am not taking any medications that affect the RAAS, as per the study team's list.
- Group 1: Women with perimenopausal depression
- Group 2: Women without perimenopausal depression
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom does this clinical trial extend its recruitment criteria?
"This research is recruiting 30 individuals aged 44-55 years that suffer from cardiovascular ailments. Specifically, we are looking for women in the late perimenopausal stage whose menstrual cycles have been absent for at least two months but no longer than one year prior to enrolment. Additionally, any antidepressant prescriptions must remain unchanged during a thirty day period before study commencement."
Are there any enrolment opportunities for individuals in this research project?
"According to the information provided on clinicaltrials.gov, recruitment for this trial ceased after its first posting and subsequent editing on October 5th 2022. Nonetheless, 1739 other studies are still searching for participants at present."
Is participation in this research open to individuals over the age of twenty?
"This clinical trial seeks patients aged 44 to 55, with 291 studies for minors and 1309 dedicated exclusively to seniors."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger